Short regimen of praziquantel in the treatment of single brain enhancing lesions
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 102 (4) , 215-218
- https://doi.org/10.1016/s0303-8467(00)00110-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis—relation with epilepsy in treated or healed neurocysticercosisThe Lancet, 1999
- Single-day praziquantel versus 1-week albendazole for neurocysticercosisNeurology, 1999
- Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trialThe Pediatric Infectious Disease Journal, 1998
- Single-Day Praziquantel Therapy for NeurocysticercosisNew England Journal of Medicine, 1996
- Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic toolClinical Neurology and Neurosurgery, 1995
- Albendazole in single CT ring lesions in epilepsyNeurology, 1994
- The Use of Albendazole in Patients with Single Lesions Enhanced on Contrast CTNew England Journal of Medicine, 1993
- Etiology and management of single small CT lesions in patients with seizures: understanding a controversyActa Neurologica Scandinavica, 1991
- Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- An Enzyme-Linked Immunoelectrotransfer Blot Assay and Glycoprotein Antigens for Diagnosing Human Cysticercosis (Taenia solium)The Journal of Infectious Diseases, 1989